Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
10/2008
10/21/2008US7439236 Pharmaceutical composition for the treatment of CNS and other disorders
10/21/2008US7439063 Providing acute neuroprotection by contacting neuronal cells with erythropoietin or active fragment or analog thereof close to or subsequent to time of excitatory insult and contacting cells with insulin-like growth factor, thereby producing synergistic acute neuroprotective effect; Alzheimer's disease
10/16/2008WO2008122098A1 Composition for promoting the maintenance and function of muscle-specific progenitor cells
10/16/2008US20080255163 Compounds such as 2-piperidino-6-methyl-5-oxo-5,6-dihydro-(7H) pyrrole-[3,4-d]pyrimidine maleate (MS-818); nervous system, brain, and neurodegenerative disorders; Parkinson's, Alzheimer's, and Huntington's disease
10/16/2008US20080255141 Modulators of signal transduction mediated by certain native and/or mutant tyrosine kinases; antiproliferative, anticarcinogenic, antiallergen, and antiinflammatory agents; metabolic and neurodegenerative disorders
10/16/2008US20080254137 Treatment of autoimmune disorders using detoxified cobratoxin
10/16/2008US20080254093 Compositions and minimally invasive methods for treating dysfunction of cardiac muscle
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/16/2008CA2682589A1 Composition for promoting the maintenance and function of muscle-specific progenitor cells
10/15/2008EP1980252A2 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
10/15/2008EP1980247A1 Growth hormone secretion regulator
10/15/2008EP1978947A2 Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
10/15/2008EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/15/2008EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1173432B9 Piperidine-indole compounds having 5-ht6 affinity
10/15/2008CN101287484A Binding agents which inhibit myostatin
10/15/2008CN101287476A Scavenger of harmful active oxygen and/or free radical in living body
10/15/2008CN101284808A Compounds and methods for the inhibition of the expression of VCAM-1
10/14/2008US7435744 Brain disorders; central nervous system disorders; viricides
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435595 Using prokaryotic histone protein as tool in transfer of heterologus nucleotide sequences into cells; improving exogenous gene expression
10/14/2008US7435547 Injectable or oral administration of a drug with an active ingredient of an extract from inflamed cutaneous tissue of rabbits inoculated with vaccinia virus; side effect reduction
10/14/2008CA2339244C Methods of ophthalmic administration
10/09/2008WO2008120778A1 Composition for promoting ketone compound formation
10/09/2008WO2008120761A1 Heteroaryl derivative
10/09/2008WO2008119571A2 Nucleic acid myostatin antagonist aptamers obtained by (mirror- image) selex
10/09/2008US20080249298 use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids
10/09/2008US20080249063 Composition for promoting the maintenance and function of muscle-specific progenitor cells
10/09/2008US20080249052 Synthetic mini/micro-dystrophin genes to restore nNOS to the sarcolemma
10/09/2008US20080248084 Method of treating acute dysfunction of cardiac muscle
10/09/2008US20080248082 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; coat suture, stent, screw, plate implants with plasma
10/09/2008US20080248081 Method of treating chronic dysfunction of cardiac muscle
10/09/2008US20080247987 devices, and methods for the production, use and administration of the composition having a non-thermoreversible block copolymer composition.
10/09/2008CA2682377A1 Heteroaryl derivatives
10/08/2008EP1977735A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders
10/08/2008EP1379246B1 Nociceptin analogs
10/08/2008EP1253918B1 Compositions comprising modafinil for the treatment of attention deficit hyperactivity disorder
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008CN101282992A Anti-myostatin antibodies
10/08/2008CN101282974A Benzimidazole derivatives as SIRTUIN modulators
10/08/2008CN101282763A Milk derived composition and use to enhance muscle mass or muscle strength
10/08/2008CN101282761A Benzimidazole derivatives as SIRTUIN modulators
10/08/2008CN101282745A B-cell reduction using CD37-specific and CD20-specific binding molecules
10/08/2008CN101279094A Treatment of T-cell mediated diseases
10/08/2008CN100424182C Methods for detecting and treating the early onset of aging-related conditions
10/08/2008CN100423777C Glycoprotein compositions
10/08/2008CN100423718C Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
10/07/2008CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives
10/07/2008CA2366841C Tolperisone-containing pharmaceutical preparation for oral administration
10/07/2008CA2359872C Gels formed by the interaction of poly(aldehyde) with various substances
10/02/2008WO2008116665A1 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
10/02/2008US20080242727 enhancing protein synthesis and decrease protein catabolism; combating muscle wasting associated with dieting and/or disease
10/02/2008US20080242695 Certain Chemical Entities, Compositions, and Methods
10/02/2008US20080242623 Microutrophin and Uses Thereof
10/02/2008US20080242619 Peptidomimetics ; determine ability to bind to growth hormone secretagogue; ghrelin antagonist; appetite stimulation; dietetics ; weight maintenance; eating disorders
10/02/2008US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241099 Inhibitors of MBP 85-99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones; multiple sclerosis; rheumatoid arthritis; solid phase synthesis; kits
10/01/2008EP1975164A2 Octahydrobenzimidazolone compounds as analgetics
10/01/2008EP1974729A1 Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
10/01/2008EP1383496B1 Treatment of fibromyalgia using pindolol
10/01/2008CN101277976A Anti-myostatin antibodies
10/01/2008CN101277965A N-phenyl benzamide derivatives as sirtuin modulators
10/01/2008CN101277963A Benzimidazole derivatives as SIRTUIN modulators
10/01/2008CN101277617A Nutriment containing betaine for curing ischemic muscular atrophy
10/01/2008CN100422316C Neutralizing human anti-IGFR antibody
10/01/2008CN100422315C Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
10/01/2008CN100422212C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
09/2008
09/30/2008US7429609 Pyrazole compound and medicinal composition containing the same
09/30/2008US7429576 treatment for osteoporosis, hypercholesterolemia, hyperlipidemia, atherosclerosis, breast cancer, endometrial cancer, ovarian cancer and uterine cancer while minimizing undesirable side effects
09/30/2008US7429488 Method for processing lipoaspirate cells
09/30/2008CA2338220C Substituted imidazoles having cytokine inhibitory activity
09/30/2008CA2314009C Triazole and imidazole derivatives
09/25/2008US20080234376 Prostaglandin E1, a phospholipid with a high purity and a non-proton-providing surfactant; hypertension, thrombosis, asthma, gastric and intestinal ulcers
09/25/2008US20080234368 Therapeutic compositions and methods of use
09/25/2008US20080234358 E-series of prostaglandin (EP) receptors; [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid
09/25/2008US20080233647 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase
09/24/2008EP1972684A1 Medium for culturing autologous human progenitor stem cells and applications
09/24/2008EP1971401A2 METHODS OF USING THE CALCINEURIN A VARIANT Cnaß1
09/24/2008CN101272793A Sphingomyelin-containing medicine, food and drink or fodder
09/24/2008CN101270362A Novel serine protease genes related to DPPIV
09/24/2008CN101269112A Traditional Chinese medicine preparation for qi-benefitting, blood-nourishing, wind-expelling and vein-relaxing and preparation method thereof
09/24/2008CN101269094A Fruit and/or vegetable derived composition
09/24/2008CN101269073A Externally used anti-inflammatory pharmaceutical composition containing piketoprofen and preparation method thereof
09/24/2008CN101269045A Galantamin hydrobromide sustained-release dropping pill and preparation method thereof
09/23/2008US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease
09/23/2008US7427598 Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory
09/23/2008US7427591 Suppression of immune response via inhibition of cathepsin S
09/23/2008US7427403 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/23/2008CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors
09/23/2008CA2371393C Use of bismuth subgallate in inhibition of production of nitric oxide synthase
09/18/2008WO2008112238A1 2, 8-dimethyl-5- [2- (6-methylpyridin-3-yl) -ethyl] -2,3,4, 5-tetrahydro- ih- pyrido [4, 3 -b] indole dihydrochloride (dimebon) for the treatment of chronic pain
09/18/2008US20080227869 Substituted nitrobenzene derivatives as pharmaceutical and other uses thereof
09/18/2008US20080227859 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
09/18/2008US20080227770 Benzoxazepine Compound
09/18/2008US20080227694 Protein composed of sequence number 1 or 2; proteasome and polyubiquitin chain inhibitors; interaction with ZNF216 and/or AWP1
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 233